MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Sonali SHARMA, Jan OPPELT, R. PYTLIK, V. PROCHAZKA, Z. PROUZOVA, Martin TRBUŠEK, L. ZLAMALIKOVA, K. LISKOVA, L. KRUZOVA, M. JAROSOVA, Andrea MAREČKOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, A.I. SCHIEFER, O. MERKEL, H. MOCIKOVA, P. BURDA, K.M. POLAKOVA, L. KREN, Jiří MAYER, C.S. ZENT, M. TRNENY, A.G. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. Washington DC, USA: American Society of Hematology, 2018, vol. 132, No 22, p. 2389-2400. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2018-06-855502.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
Authors MUSILOVÁ, Kateřina (203 Czech Republic, belonging to the institution), Ján DEVÁN (703 Slovakia, belonging to the institution), Kateřina AMRUZ ČERNÁ (203 Czech Republic, belonging to the institution), Václav ŠEDA (203 Czech Republic, belonging to the institution), Gabriela PAVLASOVÁ (203 Czech Republic, belonging to the institution), Sonali SHARMA (356 India, belonging to the institution), Jan OPPELT (203 Czech Republic, belonging to the institution), R. PYTLIK (203 Czech Republic), V. PROCHAZKA (203 Czech Republic), Z. PROUZOVA (203 Czech Republic), Martin TRBUŠEK (203 Czech Republic, belonging to the institution), L. ZLAMALIKOVA (203 Czech Republic), K. LISKOVA (203 Czech Republic), L. KRUZOVA (203 Czech Republic), M. JAROSOVA (203 Czech Republic), Andrea MAREČKOVÁ (203 Czech Republic), C. KORNAUTH (40 Austria), I. SIMONITSCH-KLUPP (40 Austria), A.I. SCHIEFER (40 Austria), O. MERKEL (40 Austria), H. MOCIKOVA (203 Czech Republic), P. BURDA (203 Czech Republic), K.M. POLAKOVA (203 Czech Republic), L. KREN (203 Czech Republic), Jiří MAYER (203 Czech Republic, belonging to the institution), C.S. ZENT (840 United States of America), M. TRNENY (203 Czech Republic), A.G. EVANS (840 United States of America), Andrea JANÍKOVÁ (203 Czech Republic, belonging to the institution) and Marek MRÁZ (203 Czech Republic, guarantor, belonging to the institution).
Edition Blood, Washington DC, USA, American Society of Hematology, 2018, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 16.601
RIV identification code RIV/00216224:14740/18:00105661
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1182/blood-2018-06-855502
UT WoS 000451634400012
Keywords in English B-CELL LYMPHOMA; TRANSCRIPTION FACTOR; T-CELLS; C-MYC; HISTOLOGIC TRANSFORMATION; COPY-NUMBER; KAPPA-B; EXPRESSION; SURVIVAL; MICRORNAS
Tags 14110212, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 13/3/2019 16:23.
Abstract
Follicular lymphoma (FL) is a common indolent B-cell malignancy with a variable clinical course. An unfavorable event in its course is histological transformation to a high-grade lymphoma, typically diffuse large B-cell lymphoma. Recent studies show that genetic aberrations ofMYC or its overexpression are associated with FL transformation (tFL). However, the precise molecular mechanisms underlying tFL are unclear. Here we performed the first profiling of expression of microRNAs (miRNAs) in paired samples of FL and tFL and identified 5 miRNAs as being differentially expressed. We focused on one of these miRNAs, namely miR-150, which was uniformly downmodulated in all examined tFLs (similar to 3.5-fold), and observed that high levels of MYC are responsible for repressing miR-150 in tFL by binding in its upstream region. This MYC-mediated repression of miR-150 in B cells is not dependent on LIN28A/B proteins, which influence the maturation of miR-150 precursor (pri-miR-150) in myeloid cells. We also demonstrated that low miR-150 levels in tFL lead to upregulation of its target, namely FOXP1 protein, which is a known positive regulator of cell survival, as well as B-cell receptor and NF-kappa B signaling in malignant B cells. We revealed that low levels of miR-150 and high levels of its target, FOXP1, are associated with shorter overall survival in FL and suggest that miR-150 could serve as a good biomarker measurable in formalin-fixed paraffin-embedded tissue. Overall, our study demonstrates the role of theMYC/miR-150/FOXP1 axis in malignant B cells as a determinant of FL aggressiveness and its high-grade transformation.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV16-29622A, research and development projectName: VLIV TERAPEUTICKÉ INHIBICE BCR SIGNALIZACE NA GENOVOU EXPRESI U B BUNĚČNÝCH MALIGNIT A JEJÍ PROGNOSTICKÝ A PREDIKTIVNÍ VÝZNAM
NV18-03-00054, research and development projectName: ÚLOHA MICRORNA A JEJICH CÍLOVÝCH MOLEKUL V TRANSFORMACI FOLIKULÁRNÍHO LYMFOMU A AGRESIVITĚ CHRONICKÉ LYMFOCYTÁRNÍ LEUKÉMIE
Investor: Ministry of Health of the CR
PrintDisplayed: 30/4/2024 13:08